First Opinion
We quit the CDC last year. The problems we protested remain
Here's how Congress can protect the health of our country
Test your knowledge with our now weekday mini crossword
Play the STAT Mini
STAT — Reporting from the frontiers of health and medicine
-
Juul gets OK to sell updated vaping device with age-gating technology
-
STAT Plus: Cytokinetics details trial win for what could be its next approval
-
A billing code was supposed to incentivize relationship-based primary care for Medicare patients. It may not be working as hoped
-
-
STAT Plus: FDA approves Roivant therapy for rare autoimmune disease
-
RFK Jr. said a Samoa trip had nothing to do with vaccines. New documents refute that
-
STAT Plus: Cassidy criticizes FDA oversight of abortion pill manufacturers in new report
Play
Top Stories
First Opinion
First Opinion
The unintended consequences of the Lindsay Clancy case
Exclusive
Health
Pharma
Most Read
Exclusive
First Opinion
First Opinion
Unraveled
Morning Rounds
Most Read In STAT+
Pharma
Exclusive
Biotech
Health tech
Special Report
Sponsored
Advertisement
-
STAT Plus: AstraZeneca and Ionis detail surprise failure of heart disease drug, with Alnylam closely watching
-
At a federal autism advisory committee meeting, members double down on long-debunked theories
-
-
STAT Plus: Pharmalittle: We’re reading about an AstraZeneca trial failure, a ‘monstrous’ conflict of interest, and more
STAT+
Your go-to source for the world of life sciences, medicine, and biopharma. Subscribe now.
Cancel anytime.
Subscribe nowTrending Now
All STAT+ Stories
STAT Plus: Former Stanford president releases emails to rebut fraud and cover-up allegations in new book
STAT Plus: The mystery of Moderna’s magic algorithm
STAT Plus: FDA approves new pancreatic cancer drug expected to usher in new era of treatment
STAT Plus: New treatments for common cardiovascular risk factor near the market, with billions at stake
STAT Plus: In autopsy of failed heart disease study, AstraZeneca raises broader questions about silencer drugs
All Events
All Events
More From STAT
More From STAT
More From STAT
Events
STAT offers a variety of in-person and virtual events throughout the year.
All Events Biosimilars: Have We Reached an Inflection Point?
Virtual
A conversation on the future of biosimilars as competition grows and policy continues to evolve.
2026 STAT Summit
Boston, MA
All Trackers
More From STAT
More From STAT
More From STAT
Trackers
We create tools to help you understand and track complex areas of development.
All Trackers
Obesity Drug Tracker
Here are the dozens of weight loss drugs in development to catch a booming market.
CRISPR Tracker
Follow the latest developments in genome editing.
Generative AI Tracker
A guide to the health systems and companies driving adoption.
Breakthrough Device Tracker
An authoritative database of FDA’s fast-tracked medical devices.
More Stories
Health
Biotech
First Opinion
Biotech
Health
Business
Adam's Biotech Scorecard
Adam's Biotech Scorecard
STAT Plus: Alnylam’s heart drug troubles take center stage at a cardiology conference
First Opinion
Opinions+
Unraveled
Exclusive
Biotech
Biotech
Adam's Biotech Scorecard
Adam's Biotech Scorecard
STAT Plus: Alnylam’s heart drug troubles take center stage at a cardiology conference
First Opinion
Biotech
Health
Exclusive
Pharmalot
The Readout
Health Tech Newsletter
Health Tech Newsletter
STAT Plus: CMS plans launch event for ACCESS, the Medicare chronic care pilot
D.C. Diagnosis
D.C. Diagnosis
STAT Plus: Hospitals plot their response to funding cuts
Pharmalot
First Opinion
First Opinion
The unintended consequences of the Lindsay Clancy case
First Opinion
First Opinion
Adam's Biotech Scorecard
Adam's Biotech Scorecard
STAT Plus: Alnylam’s heart drug troubles take center stage at a cardiology conference
First Opinion
Opinions+
Mon - Fri
Your daily dose of news in health and science
Our Picks
Our Picks
Our Picks
STAT’s selection of must-read stories and investigations
Biotech
Biotech
Biotech
Biotech
Pharmalot
Pharmalot
Pharmalot
Pharmalot
Health
Politics
Politics
Politics
Politics
Health tech
Health tech
Health tech
Health tech
In the Lab
In the Lab
In the Lab
In the Lab
Hospitals
Hospitals
Hospitals
Hospitals
Insurance
Insurance
Insurance
Insurance
